Eutos long-term survival score discriminates different Sokal score categories in chronic myeloid leukemia patients, showing better survival prediction. Analysis of the {GIMEMA} {CML} observational study

Autor:	Giovannino Ciccone, Gaetano La Barba, Giovanni Caocci, Mario Tiribelli, Anna Rita Scortechini, Bruno Martino, Giuseppe Saglio, Massimo Breccia, Antonella Gozzini, Michele Pizzuti, Fausto Castagnetti, Massimiliano Bonifacio, Fabio Stagno, Patrizia Pregno, Luigiana Luciano, Giorgina Specchia
Přispěvatelé:	Breccia M., Pregno P., Castagnetti F., Bonifacio M., Tiribelli M., Gozzini A., Scortechini A.R., Luciano L., Martino B., Stagno F., Caocci G., La Barba G., Pizzuti M., Ciccone G., Saglio G., Specchia G.
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	Oncology Male Cancer Research medicine.medical_specialty Outcome Assessment Prognosi Dasatinib Severity of Illness Index Follow-Up Studie Retrospective Studie Internal medicine Leukemia Myelogenous Chronic BCR-ABL Positive Antineoplastic Combined Chemotherapy Protocols Outcome Assessment Health Care medicine Humans Prospective Studies Chronic Prospective cohort study Survival rate Aged Retrospective Studies Antineoplastic Combined Chemotherapy Protocol Leukemia business.industry Myeloid leukemia Retrospective cohort study Hematology Middle Aged Prognosis Survival Rate Health Care Prospective Studie Imatinib mesylate Pyrimidines Pyrimidine Imatinib Mesylate Observational study Female BCR-ABL Positive Sokal Score business medicine.drug Human Follow-Up Studies Myelogenous
Popis:	NA
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94aae6c7a693d2d8a9f987f44eae5861 http://hdl.handle.net/11562/1049482 Zobrazit plný text záznamu